返回 Agenda
The Evolving Role of Clinical Biomarkers and Bio Banking in Today’s Search for Innovative Cure
Session Chair(s)
Barbara Voith, PHARMD
Head Clinical Sciences Operations
Bayer AG, Germany
Clinical biomarkers and biobanking are increasingly pivotal for patient selection, prediction of therapeutic efficacy, as well as new target selection and -validation. We will review how biomarkers are increasingly unfolding the interaction of the tumour with the immune system, the art of Biomarker sampling and -analysis, as well as the role of modern biobanks.
Speaker(s)
Connect Research and Clinical Development - Unleash the Full Power of Data and Samples to Enhance Biomarker-Based Decision Making
Barbara Voith, PHARMD
Bayer AG, Germany
Head Clinical Sciences Operations
Panel Discussion
Klaus Duecker
Merck Group, Germany
Senior Director - Clinical Biomarkers & Companion Diagnostics Biopharma
Patient Aspects of Bio Banking and Biomarker Re-Use – The Tension Field between Research and Bioethics
Jane Hair
NHS Research Scotland, United Kingdom
Biorepository Manager
Collecting Biospecimens from Cancer Patients in Trials and Routine Care: Optimising Opportunities and Research Impact
Russell Petty, PHD, FRCP
University of Dundee, United Kingdom
Professor of Medical Oncology